Breakthrough in Hepatitis C treatment


KUALA LUMPUR: In another milestone for Malaysia, a new affordable Hepatitis C combination treatment of which clinical trials have been held in the country, has shown not only a high 97% cure rate but also better efficacy of treating the most severe form of Hepatitis.

The treatment, which uses the new drug candidate ravidasvir (in combination with a generic version of sofosbuvir) has been shown to be safe and effective, with extremely high cure rates for patients, according to interim results from the Phase II/III STORM-C-1 trial.

Start your ads-free experience now!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Health , hepatitis c , clinical trials , drugs , treatment

   

Next In Nation

Masidi slams Sabah Opposition, says state's sukuk fund not another 1MDB
UMS students to go on with water protest despite no greenlight from KK cops
Three Customs officers nabbed, millions in cash seized over Port Klang smuggling ring probe
56-year-old suspected of killing wife remanded seven days in Ipoh
Ah long runner nabbed over Molotov cocktail attack in Melaka
Low wages no excuse for corruption, EAIC chief tells civil servants
Infographic: The twists and turns of the Zayn Rayyan case
BREAKING: Zayn Rayyan's murder: Parents claim trial to child neglect charge
Zayn Rayyan’s murder: Grandparents to be released on police bail
Zayn Rayyan’s murder: Parents to be charged today, says lawyer

Others Also Read